Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Announces Reverse Stock Split

Core Viewpoint - Tevogen Bio Holdings Inc. is implementing a reverse stock split to address stock price challenges and maintain its Nasdaq listing status [1][2][3] Group 1: Reverse Stock Split Details - The reverse stock split is scheduled for March 6, 2026, with a ratio of 1 share for every 50 shares [1] - The decision was approved by the Board of Directors and aims to meet the Nasdaq Global Market's $1.00 minimum bid price requirement [1][2] - Stockholder approval was granted on February 19, 2026, allowing the Board to finalize the split ratio [1] Group 2: Current Stock Performance - Currently, TVGN's stock is priced at $0.15, reflecting a 16.70% decrease with a change of $0.03 [2] - The stock has fluctuated between $0.14 and $0.18 recently, with a 52-week high of $1.51 and a low of $0.14 [2] Group 3: Market Capitalization and Trading Information - TVGN's market capitalization is approximately $31.3 million, with a trading volume of 2,180,275 shares [3] - After the reverse split, the stock will continue to trade under the symbol "TVGN" but will have a new CUSIP number, 88165K 200 [3] - The reverse split is expected to enhance the stock's appeal to investors by aligning with Nasdaq's listing requirements [3]